Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-020-00913-7
Abstract: Background and Objective Long-acting injectable antipsychotics (LAIs) have been widely studied in schizophrenia and evidence suggests that they could be also used for the treatment of bipolar and schizoaffective disorders. Nonetheless, there are no studies… read more here.
Keywords: injectable antipsychotics; aripiprazole monthly; weekly lais; long acting ... See more keywords
Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies
Sign Up to like & getrecommendations! Published in 2022 at "European Psychiatry"
DOI: 10.1192/j.eurpsy.2022.27
Abstract: Abstract Background Noninterventional naturalistic studies are an important complement to randomized controlled trials. Aripiprazole once-monthly (AOM) is an atypical antipsychotic in a long-acting injectable formulation. Methods A pooled analysis of two noninterventional studies was undertaken… read more here.
Keywords: noninterventional studies; analysis two; pooled analysis; aripiprazole monthly ... See more keywords
Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.877867
Abstract: Background One of the most significant risk factors for relapse and hospitalization in schizophrenia is non-adherence to antipsychotic medications, very common in patients with schizophrenia. The aim of this analysis was to evaluate the treatment… read more here.
Keywords: persistence; treatment persistence; analysis; risk ... See more keywords
A Noninterventional Cohort Study Assessing Time to All-Cause Treatment Discontinuation After Initiation of Aripiprazole Once Monthly or Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-Onset Schizophrenia.
Sign Up to like & getrecommendations! Published in 2021 at "The primary care companion for CNS disorders"
DOI: 10.4088/pcc.20m02886
Abstract: Introduction: Aripiprazole once-monthly 400 mg (extended-release injectable suspension) is effective in long-term maintenance treatment of schizophrenia based on clinical studies. As study results may not reflect clinical practice, we compared treatment persistence with aripiprazole once-monthly… read more here.
Keywords: daily oral; oral atypical; treatment; discontinuation ... See more keywords